Rel-3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione hydrochloride

Catalog No. :
ACZOGP761
CAS No. :
2415751-63-0
Molecular Formula :
C18H18ClF6N3O2
Molecular Weight :
457.80

IUPAC Name:3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione hydrochloride

Rel-3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione hydrochloride
IUPAC Name3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione hydrochloride
Molecular FormulaC18H18ClF6N3O2
Molecular Weight457.80
SMILESO=C1C(C(N[C@@H]2[C@@H](N)CCCC2)=C1NC3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=O.[H]Cl
InChI KeyKFDWPMCVFXASNK-FXMYHANSSA-N
Synonym3-Cyclobutene-1,2-dione, 3-[[(1R,2R)-2-aminocyclohexyl]amino]-4-[[3,5-bis(trifluoromethyl)phenyl]amino]-, hydrochloride (1:1), rel-;Rel-3-(((1S,2S)-2-aminocyclohexyl)amino)-4-((3,5-bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dionehydrochloride
CAS No.2415751-63-0

Synthetic Route by SureRoute

1. ACZOGP761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZOGP761 route product structure diagram
    ACZOGP7612415751-63-0
Inquiry

2. ACZOGP761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLENC968 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOGP761 route product structure diagram
    ACZOGP7612415751-63-0
Inquiry

Comments (0)